JSR Corp. (TYO:4185) is working on the Japanese launch of pre-clinical trial services that utilize cancer organoids, which are tumor-derived…...
Please subscribe to read the full story.
Pharma
Asahi Kasei Targets Sales of 1 Trillion Yen in Health Care Sector
Asahi Kasei Corp. (TYO:3407) is pursuing a growth strategy for its Health Care sector, with aims here being to achieve…...
Please subscribe to read the full story.
Sumitomo Dainippon Pharma to Expand Regenerative and Cellular Medicine CDMO Operations
Sumitomo Dainippon Pharma Co. Ltd. (TYO:4506) and Sumitomo Chemical Co. Ltd. (TYO:4005) plan to expand their CDMO facilities for regenerative…...
Please subscribe to read the full story.
